ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
Organ Health Publications
Read Article
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kindey health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
How to Talk to Your Doctor About Signatera for Lung Cancer
Learn how to talk to your doctor about Signatera for lung cancer recurrence monitoring. Understand the benefits of ctDNA testing, how it detects recurrence early, and why it’s vital for personalized c
Read Article
-
Natera at SABCS 2024: What It Means for Breast Cancer Survivors
Read Article
-
Cell-free DNA testing: An alternative option to surveillance biopsy in children
An overview of cell-free DNA technology and its application in pediatric heart transplantation
Watch Video
-
New data: Optimizing breast cancer care and drug development with molecular residual disease testing
Watch Video
-
Fetal RhD NIPT: Transforming care for Rh negative pregnant patients
Until recently, there has not been a reason to diverge from the standard approach of giving Rh immune globulin to all Rh negative patients. That has changed with the introduction of fetal RhD NIPT, no
Watch Video
-
Have a question or comment?
Contact Us -
JoDee & Daniel’s story
A mothers journey to enhance her sons pediatric kidney care
Watch Video
-
Clinician’s guide to Renasight results
Read More
-
Signatera for Colorectal Liver Metastases
Read More
-
Boards Preparation Event Series Winter 2025
Read More
-
A Roundtable Conversation on Post-transplant Care
Watch Video
-
Accelerating kidney disease clinical trials: The power of data driven patient recruitment
Watch Video
-
Fetal RhD NIPT Patient Video
Watch Video
-
Empower Gene Table - 81 Gene Panel Additional Cancer Risks
Read More
-
Empower Gene Table - 81 Gene Table by Panel
Read More
-
Empower Gene Table - 40 Gene Multi-Cancer Panel
Read More
-
Women's Health Publications
Read Article
-
Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort
Gilstrop Thompson, et al. OBSTETRICS & GYNECOLOGY 2024
Read Publication
-
Prospera Heart Pediatric Brochure
Read More
-
The Tipping Point: How clinically validated MRD testing is transforming patient management in colorectal cancer
Watch Video
-
Corrine’s Journey From Fear to Empowerment—Carrier Screening for Informed Pregnancies
Read Article
-
Loading More...
